Abstract
There has been a tremendous paradigm shift taking place in plastic surgery toward nonsurgical modalities in facial rejuvenation. This evolution accelerated over the last 5 years owing to the increasing demand from patients desiring less downtime and faster recovery. We have only begun to scratch the surface of what the future holds in less invasive techniques for not only the face but also the rest of the body. History has taught us to be cautious in rapidly introducing agents to fill facial defects. The search for that perfect filler would adequately fill the correct volume, be safe and biocompatible, nonteratogenic, noncarcinogenic, cause no infection, require no skin testing, and fully reversible. From the first filler agent, paraffin, to chemical agents in the early 1800s, to fat transplants in the late 1800s, the search for that perfect filler material was beginning to take shape. In the mid-twentieth century the advent of silicone changed the industry, only to be later banned due to its complications. The 1970s saw bovine collagen as the savior for facial augmentation. It ran a wonderful course until the game changer in 2006 when the FDA approved Hyaluronic acid fillers, which revolutionized the world of nonsurgical facial rejuvenation. Since then many different types of fillers have emerged on the market, and many more are on the horizon. More recently, PRP, or Plasma Rich Protein has taken the market by storm not only as filler, but also as a facial skin enhancer by attracting growth factors and stem cells.
Similar content being viewed by others
References
Sundaram H, Flynn T, Cassuto D, Lorenc ZP. New and emerging concepts in soft tissue fillers. Dermatol Surg. 2012;11(8 suppl):S12–24. discussion s25.
Myint SA. Nonsurgical periorbital rejuvenation. New York: Springer; 2013.
Rzany B, Cartier H, Kestemont P, Trevidic P, Sattler G, Kerrouche N, et al. Full face rejuvenation using a range of hyaluronic acid fillers: efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg. 2012;38(7pt2):1153–61.
Dyan SH, Arkins JP, Mathison C. Management of impending necrosis associated with soft tissue filler injections. J Drugs Dermatol. 2011;10(9):1007–12.
Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injections: a review of cause and therapy. Plast Reconstr Surg. 2014;134(6):1197–201.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Cannula filler augmentation (MOV 302106 kb)
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Myint, S. (2018). Soft Tissue Augmentation. In: Gladstone, G., Nesi, F., Black, E. (eds) Oculoplastic Surgery Atlas . Springer, Cham. https://doi.org/10.1007/978-3-319-67331-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-67331-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67330-1
Online ISBN: 978-3-319-67331-8
eBook Packages: MedicineMedicine (R0)